Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Can Vet J ; 56(8): 863-6, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26246634

RESUMO

Ketoacidosis during pregnancy carries significant risk of intrauterine fetal demise, but little is known about the impact of ketoacids on the ovine fetus. We report a case series of maternal ketoacidosis in ewes. Maternal ketoacidosis may result in biochemical and acid-base fetal abnormalities associated with changes in feto-placental unit perfusion.


Effet de l'acidocétose maternelle sur un fœtus ovin. L'acidocétose durant la gestation comporte un risque important de mortalité intra-utérine du fœtus, mais on connaît peu de choses à propos de l'impact des acides cétoniques sur le fœtus ovin. Nous signalons une série de cas d'acidocétose maternelle chez les brebis. L'acidocétose maternelle peut provoquer des anomalies biochimiques et acides avec des changements dans la perfusion de l'unité fœto-placentaire.(Traduit par Isabelle Vallières).


Assuntos
Desequilíbrio Ácido-Base/veterinária , Cetose/veterinária , Complicações na Gravidez/veterinária , Prenhez , Doenças dos Ovinos/patologia , Equilíbrio Hidroeletrolítico/efeitos dos fármacos , Desequilíbrio Ácido-Base/terapia , Animais , Feminino , Feto/patologia , Troca Materno-Fetal/efeitos dos fármacos , Placenta , Gravidez , Ovinos
2.
J Neurosci Methods ; 360: 109257, 2021 08 01.
Artigo em Inglês | MEDLINE | ID: mdl-34139266

RESUMO

BACKGROUND: The chronically instrumented pregnant sheep has been used as a model of human fetal development and responses to pathophysiologic stimuli. This is due to the unique amenability of the unanesthetized fetal sheep to the surgical placement and maintenance of catheters and electrodes, allowing repetitive blood sampling, substance injection, recording of bioelectrical activity, application of electric stimulation, and in vivo organ imaging. Recently, there has been growing interest in the pleiotropic effects of vagus nerve stimulation (VNS) on various organ systems such as innate immunity and inflammation, and metabolism. There is no approach to study this in utero and corresponding physiological understanding is scarce. NEW METHOD: Based on our previous presentation of a stable chronically instrumented unanesthetized fetal sheep model, here we describe the surgical instrumentation procedure allowing successful implantation of a cervical uni- or bilateral VNS probe with or without vagotomy. RESULTS: In a cohort of 68 animals, we present the changes in blood gas, metabolic, and inflammatory markers during the postoperative period. We detail the design of a VNS probe which also allows recording from the fetal nerve. We also present an example of fetal vagus electroneurogram (VENG) recorded from the VNS probe and an analytical approach to the data. COMPARISON WITH EXISTING METHODS: This method represents the first implementation of fetal VENG/VNS in a large pregnant mammalian organism. CONCLUSIONS: This study describes a new surgical procedure allowing to record and manipulate chronically fetal vagus nerve activity in an animal model of human pregnancy.


Assuntos
Fenômenos Fisiológicos do Sistema Nervoso , Estimulação do Nervo Vago , Animais , Modelos Animais de Doenças , Feminino , Feto , Gravidez , Ovinos , Nervo Vago
3.
Front Immunol ; 10: 1063, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31143190

RESUMO

Neuroinflammation in utero may result in lifelong neurological disabilities. Astrocytes play a pivotal role in this process, but the mechanisms are poorly understood. No early postnatal treatment strategies exist to enhance neuroprotective potential of astrocytes. We hypothesized that agonism on α7 nicotinic acetylcholine receptor (α7nAChR) in fetal astrocytes will augment their neuroprotective transcriptome profile, while the inhibition of α7nAChR will achieve the opposite. Using an in vivo-in vitro model of developmental programming of neuroinflammation induced by lipopolysaccharide (LPS), we validated this hypothesis in primary fetal sheep astrocytes cultures re-exposed to LPS in the presence of a selective α7nAChR agonist or antagonist. Our RNAseq findings show that a pro-inflammatory astrocyte transcriptome phenotype acquired in vitro by LPS stimulation is reversed with α7nAChR agonistic stimulation. Conversely, α7nAChR inhibition potentiates the pro-inflammatory astrocytic transcriptome phenotype. Furthermore, we conducted a secondary transcriptome analysis against the identical α7nAChR experiments in fetal sheep primary microglia cultures. Similar to findings in fetal microglia, in fetal astrocytes we observed a memory effect of in vivo exposure to inflammation, expressed in a perturbation of the iron homeostasis signaling pathway (hemoxygenase 1, HMOX1), which persisted under pre-treatment with α7nAChR antagonist but was reversed with α7nAChR agonist. For both glia cell types, common pathways activated due to LPS included neuroinflammation signaling and NF-κB signaling in some, but not all comparisons. However, overall, the overlap on the level of signaling pathways was rather minimal. Astrocytes, not microglia-the primary immune cells of the brain, were characterized by unique inhibition patterns of STAT3 pathway due to agonistic stimulation of α7nAChR prior to LPS exposure. Lastly, we discuss the implications of our findings for fetal and postnatal brain development.


Assuntos
Astrócitos/fisiologia , Encéfalo/metabolismo , Microglia/fisiologia , Inflamação Neurogênica/metabolismo , Receptor Nicotínico de Acetilcolina alfa7/metabolismo , Animais , Encéfalo/patologia , Bovinos , Células Cultivadas , Feto , Perfilação da Expressão Gênica , Lipopolissacarídeos/imunologia , Neuroproteção , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais
4.
Recent Pat Anticancer Drug Discov ; 5(2): 152-64, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20088766

RESUMO

Flavonoids belong to polyphenolic secondary metabolites with broad-spectrum pharmacological activities and extensive biological effects, and the most prominent activity is their potential role as anticancer agents. In recent years, flavonoids and their synthetic analogues have been intensely investigated in the treatment of ovarian, breast, cervical, pancreatic, and prostate cancer. To some extent, chemical structures of flavonoids will influence their anticancer activities. Thus, some new analogues based on the structural skeleton of these flavonoids have been synthesized and investigated. This review presents recent advances on the aspects of the natural flavonoids and their synthetic analogues in the treatment of cancers, and new synthetic approaches and possible structure-activity relationships of flavonoids are also briefly summarized.


Assuntos
Antineoplásicos/uso terapêutico , Flavonoides/uso terapêutico , Neoplasias/tratamento farmacológico , Animais , Antocianinas/farmacologia , Antocianinas/uso terapêutico , Antineoplásicos/farmacologia , Chalconas/farmacologia , Chalconas/uso terapêutico , Flavonas/farmacologia , Flavonas/uso terapêutico , Flavonoides/farmacologia , Flavonóis/farmacologia , Flavonóis/uso terapêutico , Humanos , Oncologia/legislação & jurisprudência , Oncologia/tendências , Modelos Biológicos , Patentes como Assunto
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA